1
|
Induruwa I, McKinney H, Kempster C, Thomas P, Batista J, Malcor JD, Bonna A, McGee J, Bumanlag-Amis E, Rehnstrom K, Ashford S, Soejima K, Ouwehand W, Farndale R, Downes K, Warburton E, Moroi M, Jung S. Platelet surface receptor glycoprotein VI-dimer is overexpressed in stroke: The Glycoprotein VI in Stroke (GYPSIE) study results. PLoS One 2022; 17:e0262695. [PMID: 35041713 PMCID: PMC8765640 DOI: 10.1371/journal.pone.0262695] [Citation(s) in RCA: 5] [Impact Index Per Article: 2.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/17/2021] [Accepted: 01/03/2022] [Indexed: 11/30/2022] Open
Abstract
Objectives Platelet activation underpins thrombus formation in ischemic stroke. The active, dimeric form of platelet receptor glycoprotein (GP) VI plays key roles by binding platelet ligands collagen and fibrin, leading to platelet activation. We investigated whether patients presenting with stroke expressed more GPVI on their platelet surface and had more active circulating platelets as measured by platelet P-selectin exposure. Methods 129 ischemic or hemorrhagic stroke patients were recruited within 8h of symptom onset. Whole blood was analyzed for platelet-surface expression of total GPVI, GPVI-dimer, and P-selectin by flow cytometry at admission and day-90 post-stroke. Results were compared against a healthy control population (n = 301). Results The platelets of stroke patients expressed significantly higher total GPVI and GPVI-dimer (P<0.0001) as well as demonstrating higher resting P-selectin exposure (P<0.0001), a measure of platelet activity, compared to the control group, suggesting increased circulating platelet activation. GPVI-dimer expression was strongly correlated circulating platelet activation [r2 = 0.88, P<0.0001] in stroke patients. Furthermore, higher platelet surface GPVI expression was associated with increased stroke severity at admission. At day-90 post-stroke, GPVI-dimer expression and was further raised compared to the level at admission (P<0.0001) despite anti-thrombotic therapy. All ischemic stroke subtypes and hemorrhagic strokes expressed significantly higher GPVI-dimer compared to controls (P<0.0001). Conclusions Stroke patients express more GPVI-dimer on their platelet surface at presentation, lasting at least until day-90 post-stroke. Small molecule GPVI-dimer inhibitors are currently in development and the results of this study validate that GPVI-dimer as an anti-thrombotic target in ischemic stroke.
Collapse
Affiliation(s)
- Isuru Induruwa
- Department of Clinical Neurosciences, University of Cambridge, Cambridge, United Kingdom
- * E-mail:
| | - Harriet McKinney
- Department of Haematology, University of Cambridge, Cambridge, United Kingdom
| | - Carly Kempster
- Department of Haematology, University of Cambridge, Cambridge, United Kingdom
| | - Patrick Thomas
- Department of Haematology, University of Cambridge, Cambridge, United Kingdom
| | - Joana Batista
- Department of Haematology, University of Cambridge, Cambridge, United Kingdom
| | - Jean-Daniel Malcor
- Department of Biochemistry, University of Cambridge, Cambridge, United Kingdom
| | - Arkadiusz Bonna
- Department of Biochemistry, University of Cambridge, Cambridge, United Kingdom
| | - Joanne McGee
- Department of Clinical Neurosciences, University of Cambridge, Cambridge, United Kingdom
| | - Elaine Bumanlag-Amis
- Department of Clinical Neurosciences, University of Cambridge, Cambridge, United Kingdom
| | - Karola Rehnstrom
- Department of Haematology, University of Cambridge, Cambridge, United Kingdom
| | - Sophie Ashford
- Department of Haematology, University of Cambridge, Cambridge, United Kingdom
| | - Kenji Soejima
- Research and Development Coordination and Administration Department, KM Biologics Co., Ltd, Kumamoto, Japan
| | - Willem Ouwehand
- Department of Haematology, University of Cambridge, Cambridge, United Kingdom
| | - Richard Farndale
- Department of Biochemistry, University of Cambridge, Cambridge, United Kingdom
| | - Kate Downes
- Department of Haematology, University of Cambridge, Cambridge, United Kingdom
| | - Elizabeth Warburton
- Department of Clinical Neurosciences, University of Cambridge, Cambridge, United Kingdom
| | - Masaaki Moroi
- Department of Biochemistry, University of Cambridge, Cambridge, United Kingdom
| | - Stephanie Jung
- Department of Biochemistry, University of Cambridge, Cambridge, United Kingdom
| |
Collapse
|
2
|
Turner-Stokes L, Ashford S, Jacinto J, Fheodoroff K, Maisonobe P, Senturk O, Brashear A. Botulinum toxin a in upper limb spasticity management: Baseline data from the upper limb international spasticity (ULIS)–III study. Ann Phys Rehabil Med 2018. [DOI: 10.1016/j.rehab.2018.05.150] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/28/2022]
|
3
|
Bunn L, Ashford S, Lake J, Marshall M, Bell D, Payne A. Investigating feasibility of use of an Android Smart Phone Application (MoveIt) as a clinical outcome measure. Physiotherapy 2017. [DOI: 10.1016/j.physio.2017.11.136] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/28/2022]
|
4
|
Ashford S, Jackson D, Mahaffey P, Alexandrescu R, Turner-Stokes L. Development of the leg activity measure (LEGA) for patient and care reported assessment of activity (function) in the paretic leg. Physiotherapy 2015. [DOI: 10.1016/j.physio.2015.03.223] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/30/2022]
|
5
|
Ashford S, Turner-Stokes L, Jacinto J, Fheodoroff K. Outcomes related to mobility in patients treated with botulinum toxin a (BoNT-A/INS;) for post-stroke upper-limb spasticity (ULIS-2-Study/INS;). J Neurol Sci 2013. [DOI: 10.1016/j.jns.2013.07.1930] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/26/2022]
|
7
|
Abstract
BACKGROUND AND PURPOSE This study was designed to investigate the temporal pattern of the activation and de-activation of muscles during sitting down to a seated position. The aim was to determine if reproducible patterns existed in the timing of muscle activation and deactivation, in normal subjects, and to compare that produced for sitting down with the pattern produced for standing up. METHOD The 10 subjects used for the experiment were a convenience sample consisting of healthy male volunteers aged 19-32 years. The design was that of a descriptive study. Subjects were instructed to stand up and sit back down to a seated position. During this activity kinematic (movement) and electromyographic (EMG) data were collected. A pattern of timing for the activity of different muscles or groups was produced and this was compared with the movement occurring. RESULTS The study found a consistent pattern of EMG activity during sitting down from a standing position. This pattern was documented and the pattern was compared with that produced during standing up. CONCLUSIONS The results demonstrated that a consistent pattern of muscle activation and de-activation was produced in this group of subjects during sitting down. The pattern of muscle activation and de-activation for sitting down was documented. When comparing the pattern produced during sitting down with that produced during standing up it is apparent that some of the muscles were active during both movement patterns at the same relative point in the pattern.
Collapse
Affiliation(s)
- S Ashford
- Royal Hospital for Neuro-disability, London, UK
| | | |
Collapse
|
8
|
Abstract
According to much of the theoretical literature, the psychological consequences of intergenerational occupational mobility are associated with poorer psychological health, even when upward mobility is involved. One possible explanation is that mobility results in status inconsistencies that are experienced as stressful. The research reported here reconsiders the notions that mobility is associated with higher levels of stress and that stress results from exposure to status inconsistencies. The results obtained, based on a sample of English men, provide no support for either thesis.
Collapse
Affiliation(s)
- S Ashford
- Centre for the Study of Individual and Social Values, University of Leicester, England
| |
Collapse
|